Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study

被引:103
作者
Panidis, Dimitrios [2 ]
Tziomalos, Konstantinos [1 ]
Misichronis, Georgios [2 ]
Papadakis, Efstathios [2 ]
Betsas, George [2 ]
Katsikis, Ilias [2 ]
Macut, Djuro [3 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Hosp, Propedeut Dept Internal Med 1, Thessaloniki 54636, Greece
[2] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, Thessaloniki 54636, Greece
[3] Univ Belgrade, Fac Med, Clin Endocrinol Diabet & Dis Metab, Belgrade, Serbia
关键词
polycystic ovary syndrome; phenotypes; insulin resistance; hyperandrogenemia; obesity; CARDIOVASCULAR RISK; ROTTERDAM CRITERIA; ANDROGEN EXCESS; WOMEN; PCOS; ANOVULATION; PREVALENCE; DIAGNOSIS; AGE;
D O I
10.1093/humrep/der418
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by oligo- or anovulation (ANOV), biochemical or clinical manifestations of hyperandrogenemia (HA) and PCOs. Four phenotypes of PCOS exist [phenotype 1 (ANOV + HA + PCO), phenotype 2 (ANOV + HA), phenotype 3 (HA + PCO) and phenotype 4 (ANOV + PCO)] but the differences between them are not well studied. We compared markers of insulin resistance (IR) and endocrine characteristics between the different PCOS phenotypes. METHODS: We prospectively studied 1212 consecutive women with PCOS and 254 BMI-matched healthy women. RESULTS: Phenotypes 1-4 were present in 48.2, 30.7, 9.7 and 11.4% of patients, respectively. BMI did not differ between the four phenotypes and controls. Both normal weight and overweight/obese women with phenotypes 1 and 2 were more insulin resistant than controls. Overweight/obese, but not normal weight, women with phenotype 4 were more insulin resistant than controls, while IR in women with phenotype 3 did not differ from controls regardless of obesity. In normal weight subjects, women with phenotypes 1 and 2 were more insulin resistant than women with phenotype 4. In overweight/obese subjects, women with phenotype 1 were more insulin resistant than women with phenotypes 2 and 3 and women with phenotype 4 were more insulin resistant than those with phenotype 3. Circulating androgens were higher in normal weight and overweight/obese PCOS patients with phenotypes 1-3 compared with those with phenotype 4, and higher in normal weight PCOS patients with phenotype 1 than in those with phenotype 2. CONCLUSIONS: Phenotype 1 is associated with more IR and more pronounced HA than phenotype 2. Phenotypes 2 and 4 with obesity, are also characterized by IR. In contrast, phenotype 3 is not associated with IR.
引用
收藏
页码:541 / 549
页数:9
相关论文
共 28 条
[1]   Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome [J].
Adams, JM ;
Taylor, AE ;
Crowley, WF ;
Hall, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4343-4350
[2]  
[Anonymous], 1992, POLYCYSTIC OVARY SYN
[3]   Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature [J].
Azziz, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :781-785
[4]   The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[5]   Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome [J].
Barber, Thomas M. ;
Wass, John A. H. ;
McCarthy, Mark I. ;
Franks, Stephen .
CLINICAL ENDOCRINOLOGY, 2007, 66 (04) :513-517
[6]   PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors [J].
Broekmans, F. J. ;
Knauff, E. A. H. ;
Valkenburg, O. ;
Laven, J. S. ;
Eijkemans, M. J. ;
Fauser, B. C. J. M. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (10) :1210-1217
[7]   Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism [J].
Carmina, E ;
Rosato, F ;
Jannì, A ;
Rizzo, M ;
Longo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :2-6
[8]   Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters [J].
Carmina, E ;
Chu, MC ;
Longo, RA ;
Rini, GB ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2545-2549
[9]   Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome [J].
Carmina, Enrico ;
Bucchieri, Salvo ;
Mansueto, Pasquale ;
Rini, GiovamBattista ;
Ferin, Michel ;
Lobo, Rogerio A. .
FERTILITY AND STERILITY, 2009, 91 (04) :1332-1335
[10]   INVESTIGATION OF HIRSUTISM - TESTOSTERONE IS NOT ENOUGH [J].
CARTER, GD ;
HOLLAND, SM ;
ALAGHBANDZADEH, J ;
RAYMAN, G ;
DORRINGTONWARD, P ;
WISE, PH .
ANNALS OF CLINICAL BIOCHEMISTRY, 1983, 20 (SEP) :262-263